Skip to main content

Seasonality Effect

Seasonality Effect

The seasonality effect in schizophrenia refers to the observation that the symptoms of schizophrenia appear to follow a seasonal pattern, with an increased incidence of relapse or exacerbation of symptoms during specific times of the year, such as winter. One study that investigated the seasonality effect in schizophrenia found that hospital admission rates for patients with schizophrenia were highest in the winter months and lowest in the summer months (Weiser et al., 2005). Another study found similar results, with a higher frequency of psychosis relapses in winter compared to summer months (Kilbane et al., 1996). Additionally, research has suggested that low levels of sunlight, which is more common in winter months, may play a role in the seasonal variation of symptoms in schizophrenia. For example, a study showed that exposure to bright light therapy was associated with a decrease in the severity of symptoms in patients with schizophrenia (Levine et al., 1998). In conclusion, the seasonality effect in schizophrenia is a well-documented phenomenon. Several studies have found a correlation between the severity of symptoms and the time of year, with winter months showing a higher incidence of relapse or exacerbation of symptoms. Further research is needed to fully understand this effect's underlying mechanisms and develop appropriate interventions to mitigate its impact on patients with schizophrenia.

References:

  1. Kilbane, M., Sredl, D., & Leahy, L. (1996). Seasonality in relapse of schizophrenia. The Journal of Nervous and Mental Disease, 184(12), 755-758.
  2. Levine, J., Stevens, R. J., Rousseau, M. U., & Taillard, J. (1998). Bright light therapy in winter depression with or without seasonal anxiety (DSM-IV). Journal of Affective Disorders, 50(2), 109-117.
  3. Weiser, M., Werbeloff, N., Nahon, D., Kaiserman, I., Baharav, E., Ritsner, M., & Levav, I. (2005). Hospitalization for schizophrenia and other psychotic disorders in relation to season of birth and seasonality. Journal of Psychiatric Research, 39(4), 397-401.

Comments

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)

ICD-11 Criteria for Anorexia Nervosa (6B80)

ICD-11 Criteria for Anorexia Nervosa (6B80) Anorexia Nervosa is characterised by significantly low body weight for the individual’s height, age and developmental stage that is not due to another health condition or to the unavailability of food. A commonly used threshold is body mass index (BMI) less than 18.5 kg/m2 in adults and BMI-for-age under 5th percentile in children and adolescents. Rapid weight loss (e.g. more than 20% of total body weight within 6 months) may replace the low body weight guideline as long as other diagnostic requirements are met. Children and adolescents may exhibit failure to gain weight as expected based on the individual developmental trajectory rather than weight loss. Low body weight is accompanied by a persistent pattern of behaviours to prevent restoration of normal weight, which may include behaviours aimed at reducing energy intake (restricted eating), purging behaviours (e.g. self-induced vomiting, misuse of laxatives), and behaviours aimed at incr

ICD-11 Criteria for Schizophrenia (6A20 )

ICD-11 Criteria for Schizophrenia (6A20 ) Schizophrenia is characterised by disturbances in multiple mental modalities, including thinking (e.g., delusions, disorganisation in the form of thought), perception (e.g., hallucinations), self-experience (e.g., the experience that one's feelings, impulses, thoughts, or behaviour are under the control of an external force), cognition (e.g., impaired attention, verbal memory, and social cognition), volition (e.g., loss of motivation), affect (e.g., blunted emotional expression), and behaviour (e.g., behaviour that appears bizarre or purposeless, unpredictable or inappropriate emotional responses that interfere with the organisation of behaviour). Psychomotor disturbances, including catatonia, may be present. Persistent delusions, persistent hallucinations, thought disorder, and experiences of influence, passivity, or control are considered core symptoms. Symptoms must have persisted for at least one month in order for a diagnosis of schi